Why Metabolites

Metabolites are small molecules like glucose & cholesterol that are produced during metabolic processes.

They direct readouts of both genetic & non-genetic factors associated with disease and drug response.

Metabolites are secreted to the blood from normal tissues and disease cells.

The study of <200 blood metabolites in >117,000 individuals predicted multi-disease outcomes. (Nature Medicine, 28, 2022, 2309–2320)

Our patented technology can characterize 20x more metabolites than any other platform for each patient.

We then use these large-scale metabolomic data to create digital metabolic twins, computer representations of metabolic processes within multi-omic contexts.

Learn more

How does our technology work?

Precision Cardio-metabolic

Metabolic health is currently assessed using oversimplified metrics like BMI, fasting glucose, or limited lipid panels.

We use AI and 10,000+ lipids and metabolites to develop digital metabolic twins.

Our digital metabolic twins predict metabolic health beyond BMI and risk of T2D, CVD, and other chronic diseases.

Partner with us

We believe in the power of partnerships to bring the right treatment for the right patients faster

Pipeline expansion

By utilizing multi-modal metabolomics data, we identify novel biological insights to discover new targets, prioritize them in development, explore indication expansion, and strategize drug combinations.

Optimized clinical trial design

We enhance clinical trial design by developing fine-tuned AI models based on proprietary pre-trained foundation models. These models increase the likelihood of success and decrease the size of clinical trials.

Integration with ctDNA tests

Our metabolomics data and pre-trained foundation models improve patient genetic stratification. We partner with liquid biopsy companies to increase the accuracy of their ctDNA tests by integrating metabolomics data.

Contact us

Learn more: